These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 30066855

  • 1. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Tang Q, Li M, Chen L, Bi F, Xia H.
    Int J Oncol; 2018 Oct; 53(4):1732-1742. PubMed ID: 30066855
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-200b inhibits epithelial-mesenchymal transition and migration of cervical cancer cells by directly targeting RhoE.
    Cheng YX, Chen GT, Chen C, Zhang QF, Pan F, Hu M, Li BS.
    Mol Med Rep; 2016 Apr; 13(4):3139-46. PubMed ID: 26935796
    [Abstract] [Full Text] [Related]

  • 3. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D, Guo J, Wu Y, Du J, Wang X, An J, Hu B, Kong L, Di W, Wang W.
    Theranostics; 2019 Apr; 9(7):2036-2055. PubMed ID: 31037155
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator.
    Jiao A, Sui M, Zhang L, Sun P, Geng D, Zhang W, Wang X, Li J.
    Mol Med Rep; 2016 Apr; 13(4):3349-55. PubMed ID: 26935975
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX, Zhou KC, Cao Y.
    Mol Cancer; 2014 Nov 06; 13():245. PubMed ID: 25373388
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
    Zeng X, Liu D, Peng G, Liu J, Yang H.
    Comput Math Methods Med; 2022 Nov 06; 2022():4597087. PubMed ID: 35126623
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
    Zhu L, Chen Y, Liu J, Nie K, Xiao Y, Yu H.
    Cancer Biomark; 2020 Nov 06; 29(3):347-357. PubMed ID: 32716350
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer.
    Ye MF, Zhang JG, Guo TX, Pan XJ.
    Biomed Pharmacother; 2018 Jan 06; 97():1289-1295. PubMed ID: 29156517
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Silencing of ISLR inhibits tumour progression and glycolysis by inactivating the IL‑6/JAK/STAT3 pathway in non‑small cell lung cancer.
    Zhang P, Li Z, Yang G.
    Int J Mol Med; 2021 Dec 06; 48(6):. PubMed ID: 34713300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.